Good trial results for NASH treatment

I reported previously (Oct 2014) that the Aramchol treatment from Israel’s Galmed for Non-Alcoholic Steatohepatitis (NASH) had been fast-tracked by the US FDA. Latest trials show that twice-daily dosages of Aramchol significantly increased blood plasma levels.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *